 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/26/2026 |
$59.00 |
$59.07 |
$58.05 |
$58.07 |
6.22M | | 02/27/2026 |
$58.43 |
$59.36 |
$58.33 |
$59.13 |
5.98M | | 03/02/2026 |
$58.56 |
$58.87 |
$58.00 |
$58.29 |
3.17M | | 03/03/2026 |
$56.82 |
$57.35 |
$56.16 |
$57.07 |
3.91M | | 03/04/2026 |
$57.02 |
$57.03 |
$56.29 |
$56.83 |
3.82M |
 |
| GSK plc is a global biopharma company. Co.'s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. | |
 |

GSK (GSK) has the following price history information. Looking back at GSK historical stock prices for the last five trading days, on February 26, 2026, GSK opened at $59.00, traded as high as $59.07 and as low as $58.05, and closed at $58.07. Trading volume was a total of 6.22M shares. On February 27, 2026, GSK opened at $58.43, traded as high as $59.36 and as low as $58.33, and closed at $59.13. Trading volume was a total of 5.98M shares. On March 02, 2026, GSK opened at $58.56, traded as high as $58.87 and as low as $58.00, and closed at $58.29. Trading volume was a total of 3.17M shares. On March 03, 2026, GSK opened at $56.82, traded as high as $57.35 and as low as $56.16, and closed at $57.07. Trading volume was a total of 3.91M shares. On March 04, 2026, GSK opened at $57.02, traded as high as $57.03 and as low as $56.29, and closed at $56.83. Trading volume was a total of 3.82M shares.
GSK Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into GSK shares, starting with a $10,000 purchase of GSK, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
03/08/2016 |
|
| End date: |
03/04/2026 |
|
| Start price/share: |
$39.71 |
|
| End price/share: |
$56.83 |
|
| Starting shares: |
251.83 |
|
| Ending shares: |
403.46 |
|
| Dividends reinvested/share: |
$18.84 |
|
| Total return: |
129.28% |
|
| Average Annual Total Return: |
8.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$22,935.03 |
|
| Years: |
9.99 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/08/2016 |
|
| End date: |
03/04/2026 |
|
| Start price/share: |
$39.71 |
|
| End price/share: |
$56.83 |
|
| Dividends collected/share: |
$18.84 |
|
| Total return: |
90.55% |
|
| Average Annual Total Return: |
6.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$19,048.57 |
|
| Years: |
9.99 |
|
|
 |
| Date |
Close |
| 02/26/2026 | $58.07 | | 02/27/2026 | $59.13 | | 03/02/2026 | $58.29 | | 03/03/2026 | $57.07 | | 03/04/2026 | $56.83 |
|
 |